These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16984374)
1. Suppression of azoxymethane-induced colon cancer development in rats by a cyclooxygenase-1 selective inhibitor, mofezolac. Niho N; Kitamura T; Takahashi M; Mutoh M; Sato H; Matsuura M; Sugimura T; Wakabayashi K Cancer Sci; 2006 Oct; 97(10):1011-4. PubMed ID: 16984374 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis. Kitamura T; Kawamori T; Uchiya N; Itoh M; Noda T; Matsuura M; Sugimura T; Wakabayashi K Carcinogenesis; 2002 Sep; 23(9):1463-6. PubMed ID: 12189188 [TBL] [Abstract][Full Text] [Related]
3. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374 [TBL] [Abstract][Full Text] [Related]
4. Chemopreventive effect of mofezolac on beef tallow diet/azoxymethane-induced colon carcinogenesis in rats. Miao L; Shiraishi R; Fujise T; Kuroki T; Kakimoto T; Sakata Y; Takashima T; Iwakiri R; Fujimoto K; Shi R; Li X Hepatogastroenterology; 2011; 58(105):81-8. PubMed ID: 21510291 [TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate. Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Reddy BS; Rao CV; Seibert K Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961 [TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834 [TBL] [Abstract][Full Text] [Related]
9. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Kawamori T; Rao CV; Seibert K; Reddy BS Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081 [TBL] [Abstract][Full Text] [Related]
10. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. Takahashi M; Fukutake M; Yokota S; Ishida K; Wakabayashi K; Sugimura T J Cancer Res Clin Oncol; 1996; 122(4):219-22. PubMed ID: 8601574 [TBL] [Abstract][Full Text] [Related]
11. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats. Yoshimi N; Kawabata K; Hara A; Matsunaga K; Yamada Y; Mori H Jpn J Cancer Res; 1997 Nov; 88(11):1044-51. PubMed ID: 9439679 [TBL] [Abstract][Full Text] [Related]
13. S-adenosyl L-methionine inhibits azoxymethane-induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco-2 cell growth in 3D culture. Guruswamy S; Swamy MV; Choi CI; Steele VE; Rao CV Int J Cancer; 2008 Jan; 122(1):25-30. PubMed ID: 17724725 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of benzyl selenocyanate glutathione conjugate for potential chemopreventive properties in colon carcinogenesis. Kawamori T; El-Bayoumy K; Ji BY; Rodriguez JG; Rao CV; Reddy BS Int J Oncol; 1998 Jul; 13(1):29-34. PubMed ID: 9625800 [TBL] [Abstract][Full Text] [Related]
15. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention. Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288 [TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of colon carcinogenesis by oleanolic acid and its analog in male F344 rats and modulation of COX-2 and apoptosis in human colon HT-29 cancer cells. Janakiram NB; Indranie C; Malisetty SV; Jagan P; Steele VE; Rao CV Pharm Res; 2008 Sep; 25(9):2151-7. PubMed ID: 18408893 [TBL] [Abstract][Full Text] [Related]
18. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane. Yoshimi N; Shimizu M; Matsunaga K; Yamada Y; Fujii K; Hara A; Mori H Jpn J Cancer Res; 1999 Apr; 90(4):406-12. PubMed ID: 10363578 [TBL] [Abstract][Full Text] [Related]
19. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid. Kawamori T; Tanaka T; Kojima T; Suzui M; Ohnishi M; Mori H Jpn J Cancer Res; 1994 Jul; 85(7):686-91. PubMed ID: 8071110 [TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats. Kawamori T; Tanaka T; Ohnishi M; Hirose Y; Nakamura Y; Satoh K; Hara A; Mori H Cancer Res; 1995 Sep; 55(18):4053-8. PubMed ID: 7664279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]